Gabriella Collu

959 citations

36 papers · 779 indexed · h-index 18

Co-authors: Paolo La Colla Roberta Loddo Giuseppina Sanna Antonio Carta Giuseppe Paglietti Maurizio Fermeglia Sabrina Pricl Adel Moussa
Topics: HIV/AIDS drug development and treatment (17 papers)HIV Research and Treatment (8 papers)Synthesis and biological activity (8 papers)
Cited by: Organic Chemistry Virology Infectious Diseases
Journals: Nano Letters Journal of Medicinal Chemistry Journal of Experimental Botany
Partner nations: Italy Denmark Switzerland

In The Last Decade

Gabriella Collu

35 papers receiving 767 citations

Peers

Countries citing papers authored by Gabriella Collu

Since Specialization

Citations

This map shows the geographic impact of Gabriella Collu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Collu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Collu more than expected).

Fields of papers citing papers by Gabriella Collu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriella Collu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Collu. The network helps show where Gabriella Collu may publish in the future.

Co-authorship network of co-authors of Gabriella Collu

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriella Collu. A scholar is included among the top collaborators of Gabriella Collu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriella Collu. Gabriella Collu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors 2025 ·Nano Letters ·(unknown),(unknown),(unknown),Gabriella Collu,Erik Bos,(unknown),Lukas J.A.C. Hawinkels,Nadine van Montfoort,Ferenc A. Scheeren,Thomas H. Sharp	0
2	Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives 2021 ·Frontiers in Chemistry ·Roberta Ibba,Sandra Piras,Paola Corona,(unknown),Roberta Loddo,Ilenia Delogu,Gabriella Collu,Giuseppina Sanna,Paola Caria,Tinuccia Dettori,Antonio Carta	13
3	Design, Expression, Purification, and Characterization of a YFP-Tagged 2019-nCoV Spike Receptor-Binding Domain Construct 2020 ·Frontiers in Bioengineering and Biotechnology ·(unknown),Gabriella Collu,Alain Blanc,(unknown),Roger Benoit	10
4	Seamless insert-plasmid assembly at sub-terminal homologous sequences 2019 ·Plasmid ·Anna-Sophia Krebs,(unknown),Gabriella Collu,Roger Benoit	1
5	Design, Synthesis, Antiviral Evaluation, and SAR Studies of New 1-(Phenylsulfonyl)-1H-Pyrazol−4-yl-Methylaniline Derivatives 2019 ·Frontiers in Chemistry ·Nicoletta Desideri,Rossella Fioravanti,(unknown),(unknown),Antonio Carta,Ilenia Delogu,Gabriella Collu,Roberta Loddo	22
6	Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation 2017 ·European Journal of Medicinal Chemistry ·Rossella Fioravanti,Nicoletta Desideri,Antonio Carta,(unknown),Ilenia Delogu,Gabriella Collu,Roberta Loddo	16
7	Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents 2015 ·European Journal of Medicinal Chemistry ·Andrea Spallarossa,(unknown),(unknown),Silvana Alfei,Stefania Butini,Giuseppe Campiani,Sandra Gemma,Margherita Brindisi,Daniela M. Zisterer,Sandra A. Bright,D. Clive Williams,Emmanuele Crespan,Giovanni Maga,Giuseppina Sanna,Ilenia Delogu,Gabriella Collu,Roberta Loddo	12
8	Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 2015 ·Bioorganic & Medicinal Chemistry ·Roberta Loddo,Federica Novelli,Anna Sparatore,Bruno Tasso,Michele Tonelli,Vito Boido,Fabio Sparatore,Gabriella Collu,Ilenia Delogu,Gabriele Giliberti,Paolo La Colla	22
9	Aryl nucleoside H-phosphonates. Part 16: Synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters 2009 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Jerzy Boryski,Jacek Stawiński,Adam Kraszewski,Roberta Loddo,Giuseppina Sanna,Gabriella Collu,(unknown),Paolo La Colla	18
10	Synthesis of Novel Uracil Non‐Nucleoside Derivatives as Potential Reverse Transcriptase Inhibitors of HIV‐1 2009 ·Archiv der Pharmazie ·Nasser R. El‐Brollosy,Omar A. Al‐Deeb,Ali A. El‐Emam,Erik B. Pedersen,Paolo La Colla,Gabriella Collu,Giuseppina Sanna,Roberta Loddo	23
11	Synthesis, pharmacological and antiviral activity of 1,3-thiazepine derivatives 2009 ·European Journal of Medicinal Chemistry ·Marta Struga,Jerzy Kossakowski,A.E. Kozioł,Ewa Kędzierska,Sylwia Fidecka,Paolo La Colla,Cristina Ibba,Gabriella Collu,Giuseppina Sanna,(unknown),Roberta Loddo	24
12	Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives 2009 ·Bioorganic & Medicinal Chemistry ·Michele Tonelli,Iana Vazzana,Bruno Tasso,Vito Boido,Fabio Sparatore,Maurizio Fermeglia,Maria Silvia Paneni,Paola Posocco,Sabrina Pricl,Paolo La Colla,Cristina Ibba,(unknown),Gabriella Collu,Roberta Loddo	83
13	Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors 2008 ·European Journal of Medicinal Chemistry ·Andrea Spallarossa,Sara Cesarini,Angelo Ranise,Olga Bruno,Silvia Schenone,Paolo La Colla,Gabriella Collu,Giuseppina Sanna,(unknown),Roberta Loddo	20
14	Parallel synthesis, molecular modelling and further structure–activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitors 2008 ·European Journal of Medicinal Chemistry ·Andrea Spallarossa,Sara Cesarini,Angelo Ranise,Silvia Schenone,Olga Bruno,(unknown),Paolo La Colla,Margherita Pezzullo,Giuseppina Sanna,Gabriella Collu	17
15	Parallel one-pot synthesis and structure–activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors 2008 ·Bioorganic & Medicinal Chemistry ·Sara Cesarini,Andrea Spallarossa,Angelo Ranise,Silvia Schenone,Olga Bruno,Paolo La Colla,Laura Casula,Gabriella Collu,Giuseppina Sanna,Roberta Loddo	14
16	Synthesis and Anti-Picornaviridae In Vitro Activity of a New Class of Helicase Inhibitors the N,N-bis[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl] alkyldicarboxamides 2007 ·Medicinal Chemistry ·Antonio Carta,Mario Loriga,Sandra Piras,Giuseppe Paglietti,Marco Ferrone,Maurizio Fermeglia,Sabrina Pricl,P. La Colla,Gabriella Collu,(unknown),Roberta Loddo	24
17	Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Parallel synthesis, molecular modelling and structure–activity relationship studies on O-[2-(hetero)arylethyl]-N-phenylthiocarbamates 2007 ·Bioorganic & Medicinal Chemistry ·Sara Cesarini,Andrea Spallarossa,Angelo Ranise,Paola Fossa,Paolo La Colla,Giuseppina Sanna,Gabriella Collu,Roberta Loddo	14
18	Synthesis and In Vitro Evaluation of the Anti-Viral Activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 2006 ·Medicinal Chemistry ·Antonio Carta,Giovanni Loriga,Sandra Piras,Giuseppe Paglietti,Marco Ferrone,Maurizio Fermeglia,Sabrina Pricl,Paolo La Colla,(unknown),Gabriella Collu,Roberta Loddo	44
19	Synthesis of Variously Substituted 3-Phenoxymethyl Quinoxalin-2-Ones and Quinoxalines Capable to Potentiate In Vitro the Antiproliferative Activity of Anticancer Drugs in Multi-Drug Resistant Cell Lines 2006 ·Medicinal Chemistry ·Roberta Loddo,Paolo La Colla,Bernardetta Busonera,Gabriella Collu,Giuseppe Paglietti,Sandra Piras,Antonio Carta,Mario Loriga	43
20	Aryl nucleoside H-phosphonates. Part 15: Synthesis, properties and, anti-HIV activity of aryl nucleoside 5′-α-hydroxyphosphonates 2005 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Jerzy Boryski,Jacek Stawiński,Adam Kraszewski,Gabriella Collu,Giuseppina Sanna,Gabriele Giliberti,Roberta Loddo,Paolo La Colla	51

About Gabriella Collu

Gabriella Collu is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 36 papers that have together received 779 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (17 papers), HIV Research and Treatment (8 papers) and Synthesis and biological activity (8 papers). The work is most often cited by research in Organic Chemistry (464 citations), Virology (63 citations) and Infectious Diseases (233 citations). Gabriella Collu has collaborated with scholars based in Italy, Denmark and Switzerland. Frequent co-authors include Paolo La Colla, Roberta Loddo, Giuseppina Sanna, Antonio Carta, Giuseppe Paglietti, Maurizio Fermeglia, Sabrina Pricl, Adel Moussa, Bruno Canard and Sandra Piras. Their work appears in journals such as Nano Letters, Journal of Medicinal Chemistry and Journal of Experimental Botany.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact